The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective

1. Introduction.- 2. Guidelines for analysing and reporting EQ-5D outcomes.- 3. EQ-5D: Modes of administration.- 4. Guidelines for value sets in economic and non-economic studies using EQ-5D.- 5. Test-retest performance of EQ-5D.- 6. Construction of the EQ-net VAS and TTO databases.- 7. Comparison of EQ-5D VAS valuations: analysis of background variables.- 8. A European EQ-5D VAS valuation set.- 9. A comparison of EQ-5D time trade-off values obtained in Germany, The United Kingdom and Spain.- 10. What concepts does the EQ-5D measure? Intentions and interpretations.- 11. Producing other language versions of the EQ-5D.- 12. Exploring the results of translating the EQ-5D into 11 European languages.- 13. EQ-5D in selected countries around the world.- 14. Summary and future EQ-5D work.- References for all chapters.- Appendices.

[1]  Jacob Cohen,et al.  Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit. , 1968 .

[2]  T. M. Kashner,et al.  Patient-proxy response comparability on measures of patient health and functional status. , 1988, Journal of clinical epidemiology.

[3]  P. Kind,et al.  A Comparison of United Kingdom and Spanish General Population Time Trade-off Values for EQ-5D Health States , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.

[4]  Paul Kind,et al.  Variations in population health status: results from a United Kingdom national questionnaire survey , 1998, BMJ.

[5]  Nancy Devlin,et al.  Variations in self-reported health status: results from a New Zealand survey. , 2000, The New Zealand medical journal.

[6]  P. Kind,et al.  The health state preferences and logistical inconsistencies of New Zealanders: a tale of two tariffs , 2000 .

[7]  N. Ikegami,et al.  EuroQol Study of the Elderly General Population , 2000 .

[8]  C. Bombardier,et al.  Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. , 1993, Journal of clinical epidemiology.

[9]  R. Hays,et al.  Responsiveness to change: an aspect of validity, not a separate dimension , 1992, Quality of Life Research.

[10]  P. Dolan,et al.  The time trade-off method: results from a general population study. , 1996, Health economics.

[11]  R. Gelber,et al.  Quality-of-life assessment in clinical trials. , 1995, Cancer treatment and research.

[12]  Edith de Leeuw,et al.  Technological Innovations in Data Collection: Acceptance, Data Quality and Costs , 1996 .

[13]  A. Wu,et al.  The effect of mode of administration on Medical Outcomes Study health ratings and EuroQol scores in AIDS , 2004, Quality of Life Research.

[14]  T. Wobbes,et al.  Quality of life as an outcome measure in surgical oncology , 2001, The British journal of surgery.

[15]  M. Essink‐bot,et al.  Estimating parametric relationships between health description and health valuation with an application to the EuroQol EQ-5D. , 1999, Journal of health economics.

[16]  Jørgen Lauridsen,et al.  Estimating Danish EQ-5D Tariffs Using the Time-Trade-Off (TTO) and Visual Analogue Scale (VAS) Methods , 2002 .

[17]  A. Norinder,et al.  The weighting exercise for the Swedish version of the EuroQol. , 1999, Health economics.

[18]  G. Guyatt,et al.  Interpreting treatment effects in randomised trials , 1998, BMJ.

[19]  J. Busschbach,et al.  Observations on one hundred students filling in the EuroQol questionnaire , 2005 .

[20]  E. Fernández,et al.  Influence of socio-demographic and health status variables on evaluation of health states in a Spanish population , 1995 .

[21]  X. Badia,et al.  Re-scaling the Spanish version of the Sickness Impact Profile: an opportunity for the assessment of cross-cultural equivalence. , 1995, Journal of clinical epidemiology.

[22]  N. Ikegami,et al.  Estimating an EQ-5D population value set: the case of Japan. , 2002, Health economics.

[23]  T. Peters,et al.  Use of the EuroQoL among elderly acute care patients , 2004, Quality of Life Research.

[24]  G. Regehr,et al.  Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach. , 1997, Journal of clinical epidemiology.

[25]  P. Dolan,et al.  Valuing health status using VAS and TTO: what lies behind the numbers? , 1997, Social science & medicine.

[26]  G. Bonsel,et al.  Test-retest reliability of health state valuations collected with the EuroQol questionnaire. , 1994, Social Science & Medicine (1967).

[27]  P Glasziou,et al.  Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Steven M. Albert,et al.  Assessing quality of life in Alzheimer's disease , 1999 .

[29]  J. Fox-Rushby.  First steps to assessing semantic equivalence of the EuroQol Instrument: Results of a questionnaire survey to members of the EuroQol Group , 2005 .

[30]  G. Bonsel,et al.  The Impact of Migraine on Health Status , 1995, Headache.

[31]  M. Johannesson,et al.  Standard gamble, time trade-off and rating scale: experimental results on the ranking properties of QALYs. , 1997, Journal of health economics.

[32]  S. Siegel,et al.  Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.

[33]  Māori health state preferences: a pilot study * , 2001 .

[34]  P. Dolan,et al.  Modeling valuations for EuroQol health states. , 1997, Medical care.